Access issues due to cost and availability causes disparities in biologics use; cancer risk is minimal and there is much more on the horizon for hidradenitis suppurativa, researchers say at AAD 2018.
Modern medicine – dermatology
Tag Archives: Biologics
Herpes zoster rates stay steady with biologics in psoriasis
Study shows no significant difference in herpes zoster risk between psoriasis patients receiving systemic therapy and those not receiving systemic therapy.
Dermatology Times – Dermatology
Genetic variation may explain why biologics help some patients, but fail others
Psoriasis patients carrying a specific gene experience a significantly better early response to ustekinumab, but are less likely to achieve high rates of response to anti-TNFs.
Dermatology Times – Dermatology
A comparison of plaque psoriasis biologics and biosimilars
Switching from originator to biosimilar shows no significant impact on drug survival in plaque psoriasis, but outcomes differ, researchers report.
Dermatology Times – Dermatology